For this analysis, we focused on expression changes related to inflammatory markers that indicate progression of NAFLD towards a NASH pathology, specifically IL-1α, IL-1β, Ifnγ, and TNFα. This evidence concerns the gene IL1B and metabolic dysfunction-associated steatotic liver disease.